Possible diagnostic role of antibodies to Crohn's disease peptide (ACP): Results of a multicenter study in a Japanese cohort

Journal of Gastroenterology

Volumn 49, Issue 4, 2014, Pages 683-691

  Mitsuyama, Keiichi ^a   Niwa, Mikio ^b   Masuda, Junya ^a   Yamasaki, Hiroshi ^a   Kuwaki, Kotaro ^a   Takedatsu, Hidetoshi ^a   Kobayashi, Teppei ^a   Kinjo, Fukunori ^c   Kishimoto, Kazuto ^c   Matsui, Toshiyuki ^d   Hirai, Fumihito ^d   Makiyama, Kazuya ^e   Ohba, Kazuo ^e   Abe, Hiroo ^f   Tsubouchi, Hirohito ^g   Fujita, Hiroshi ^g   Maekawa, Ryuichiro ^a,i   Yoshida, Hiroshi ^a,h   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Base Technology Center   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

^d Fukuoka University Chikushi Hospital   (Japan)

^e NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF MIYAZAKI   (Japan)

^g KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^h Yame General Hospital   (Japan)

ⁱ Social Insurance Tagawa Hospital   (Japan)

Author keywords

Biomarker; Crohn's disease; Inflammatory bowel disease; Phage display; Ulcerative colitis

Indexed keywords

ACYL CARRIER PROTEIN; AMINOSALICYLIC ACID; FUNGUS ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; SACCHAROMYCES CEREVISIAE ANTIBODY; STEROID; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; PEPTIDE; TCP-353 PEPTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE DURATION; ELEMENTAL DIET; ENTEROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TOTAL PARENTERAL NUTRITION; ULCERATIVE COLITIS; AREA UNDER THE CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CLINICAL TRIAL; COLITIS, ULCERATIVE; COLON; DIFFERENTIAL DIAGNOSIS; ILEUM; IMMUNOLOGY; JAPAN; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; SACCHAROMYCES CEREVISIAE; SEVERITY OF ILLNESS INDEX; TIME; YOUNG ADULT;

ADULT; ANTIBODIES, BACTERIAL; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; ILEUM; IMMUNOGLOBULIN G; JAPAN; MALE; MIDDLE AGED; PEPTIDES; ROC CURVE; SACCHAROMYCES CEREVISIAE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84899929712     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0916-9     Document Type: Article

References (32)

1. Schreiber S, Rosenstiel P, Albrecht M, et al. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet. 2005;6:376-88. (Pubitemid 40577181)
2. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627-40. (Pubitemid 46722636)
3. Hamilton MJ, Snapper SB, Blumberg RS. Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance. J Gastroenterol. 2012;47:1-8.
4. Beaven SW, Abreu MT. Biomarkers in inflammatory bowel disease. Curr Opin Gastroenterol. 2004;20:318-27. (Pubitemid 38813672)
5. Sandborn WJ. Serologic markers in inflammatory bowel disease: state of the art. Rev Gastroenterol Disord. 2004;4:167-74. (Pubitemid 40012216)
6. Targan SR, Karp LC. Serology and laboratory markers of disease activity. In: Sartor RB, Sandborn WJ, editors. Kirsner's Inflammatory bowel diseases. 6th ed. Philadelphia: Saunders; 2004. p. 442-50.
7. Rutgeerts P, Vermeire S. Serological diagnosis of inflammatory bowel disease. Lancet. 2000;356:2117-8. (Pubitemid 32047944)
8. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42:788-91. (Pubitemid 28277217)
9. Rump JA, Roth M, Scholmerich J, et al. A new type of ANCA in sera of patients with ulcerative colitis: effects of therapy and disease severity on serum titer. Immun Infekt. 1992;20:16-8.
10. Saxon A, Shanahan F, Landers C, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990;86:202-10. (Pubitemid 20288725)
11. Main J, McKenzie H, Yeaman GR, et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ. 1988;297:1105-6.
12. Gironella M, Iovanna JL, Sans M, et al. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease. Gut. 2005;54:1244-53. (Pubitemid 41192482)
13. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to autoand microbial antigens. Gastroenterology. 2002;123:689-99. (Pubitemid 34977074)
14. Mow WS, Vasiliauskas EA, Lin YC, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology. 2004;126:414-24. (Pubitemid 38182298)
15. Wei B, Huang T, Dalwadi H, et al. Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen. Infect Immun. 2002;70:6567-75. (Pubitemid 35387882)
16. Dalwadi H, Wei B, Kronenberg M, et al. The Crohn's disease-associated bacterial protein I2 is a novel enteric t cell superantigen. Immunity. 2001;15:149-58. (Pubitemid 32728328)
17. Sutton CL, Kim J, Yamane A, et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology. 2000;119:23-31. (Pubitemid 30452575)
18. Sitaraman SV, Klapproth JM, Moore DA 3rd, et al. Elevated flagellin-specific immunoglobulins in Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2005;288:G403-6. (Pubitemid 40129593)
19. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest. 2004;113:1296-306. (Pubitemid 39069929)
20. Hisabe T, Matsui T, Sakurai T, et al. Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value. J Gastroenterol. 2003;38:121-6. (Pubitemid 36372285)
21. Oshitani N, Hato F, Matsumoto T, et al. Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn's disease. J Gastroenterol Hepatol. 2000;15:1400-3. (Pubitemid 32052913)
22. Kim BC, Park S, Han J, et al. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course. Dig Liver Dis. 2007;39:610-6. (Pubitemid 46888207)
23. Mitsuyama K, Niwa M, Masuda J, et al. Isolation and characterization of a novel short peptide associated with Crohn's disease. Clin Exp Immunol. 2011;166:72-9.
24. Santi E, Capone S, Mennuni C, et al. Bacteriophage lambda display of complex cDNA libraries: a new approach to functional genomics. J Mol Biol. 2000;296:497-508.
25. Niwa M, Maruyama H, Fujimoto T, et al. Affinity selection of cDNA libraries by lambda phage surface display. Gene. 2000;256:229-36.
26. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-44.
27. Ueno F, Matsui T, Matsumoto T, et al. Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan. J Gastroenterol. 2013;48:31-72.
28. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041-8.
29. Saito H, Fukuda Y, Katsuragi K, et al. Isolation of peptides useful for differential diagnosis of Crohn's disease and ulcerative colitis. Gut. 2003;52:535-40. (Pubitemid 36363407)
30. Oshitani N, Hato F, Kitagawa S, et al. Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease. Clin Diagn Lab Immunol. 2003;10:856-61. (Pubitemid 37129499)
31. Oshitani N, Hato F, Kitagawa S, et al. Analysis of intestinal HLA-DR bound peptides and dysregulated immune responses to enteric flora in the pathogenesis of inflammatory bowel disease. Int J Mol Med. 2003;11:99-104.
32. Elsaghier A, Prantera C, Moreno C, et al. Antibodies to Mycobacterium paratuberculosis - specific protein antigens in Crohn's disease. Clin Exp Immunol. 1992;90:503-8. (Pubitemid 23001823)